Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials - Test2 - elhamkhani - TriplyDB

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

http://www.wikidata.org/entity/Q28078703

about

Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.Drug discovery for remyelination and treatment of MS.Wnt Signaling in Ewing Sarcoma, Osteosarcoma, and Malignant Peripheral Nerve Sheath Tumors.Non-canonical WNT/PCP signalling in cancer: Fzd6 takes centre stage.Wnt/β-catenin pathway in arrhythmogenic cardiomyopathy.Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting.WNT signaling, the development of the sympathoadrenal-paraganglionic system and neuroblastoma.PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling.β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.WNTing no RASt for hepatocellular carcinoma.Lung Cancer Chemopreventive Activity of Patulin Isolated from Penicillium vulpinum Wnt/β-catenin signaling regulates VE-cadherin-mediated anastomosis of brain capillaries by counteracting S1pr1 signaling

P2860

Q39345895-7D41C48B-0DD3-4274-888F-44C6CDCC2979 Q39375830-6411E181-D223-488E-AC9A-61FE0ADCAE71 Q39396803-0ACC0EE5-3CC9-4636-8D38-0F92AB5AC146 Q39454318-F10D1117-977C-4C9B-B9BF-07B6E6560518 Q41694294-3A89AE3B-DAFE-4BA8-B552-5EEBA986F39E Q47215094-88CC62A3-97AB-4782-84B9-F6F3E36F130A Q47618158-BF304771-2C53-4F2D-AF6B-EA55C44CFF2B Q48507592-AB7F36F3-DA37-450B-9C45-804277E6A7E5 Q49547317-8D61D789-E78D-43F1-B231-BEDFBFE53B21 Q52782089-488419DE-A9FF-4861-89D9-9DA0C9EA9705 Q58855963-C4FD234C-4CAE-4291-8756-2D88587DC70A Q59134756-95793288-8F56-4E42-AB9A-6BEFC42ADFA7

P2860

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

http://www.wikidata.org/entity/Q28078703

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@ast

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@en

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@nl

type

label

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@ast

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@en

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@nl

prefLabel

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@ast

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@en

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@nl

P1433

Q28078703-D2788E32-F321-4652-92AD-9D5770CFC06F

P1476

Q28078703-3CEB7E0C-0C4D-40F0-A95A-07DE61A08AC2

P2093

Q28078703-36713D83-4883-4FC6-B4A1-E31630152706

Q28078703-8521F6A4-FF53-4303-BD4C-6AD68A765177

Q28078703-987EF85B-CCC0-42E0-B15B-53F0703485ED

Q28078703-AE170AE5-F108-41A4-915A-6ED4656168CF

Q28078703-D6AC6F78-1EC2-43C1-9308-235CF945F069

P2860

Q28078703-064674FE-297E-440A-9B98-D315B085E989

Q28078703-090C2D04-7A27-4C14-B145-467FF3335250

Q28078703-09692ECD-64A6-4155-8070-608C1E45ED4D

Q28078703-0A16E30E-39BA-4ED0-8491-18580D748F69

Q28078703-0B2C66FF-1671-4681-AB3C-60CA1075A0B9

Q28078703-0BD6AD28-3FF4-4FA5-B209-D7128ABA380E

Q28078703-0DB6341E-593C-4B27-BBF6-E756114855A3

Q28078703-1309A35E-329D-4555-9E15-810E2756BF23

Q28078703-14DA6F47-C672-4FC8-96C0-BE460AC9BF04

Q28078703-18C003EF-562C-492C-9660-3404B2A1643A

P31

Q28078703-8055B1A6-21DD-4410-B339-0E0F0C67BEC5

P3181

Q28078703-376840B2-8514-4D5B-88AD-E9E759A8119C

P356

Q28078703-3C1F697C-5C8E-48AA-B47A-3743B88DDFF3

P407

Q28078703-80D633DE-F22E-4F2B-86C4-F79CA533BE25

P433

Q28078703-1FD398A6-6DEA-4643-BED8-FB35A727BC54

P478

Q28078703-0DAE73EA-F689-418E-A11A-B8019B23D27E

P577

Q28078703-659F9CBC-4AC0-4549-BDC6-75C56063D99B

P698

Q28078703-85130B6E-405D-4722-AEB1-882AEED011A8

P921

Q28078703-298663C3-F066-4159-86A3-9E9B02EEBDEC

Q28078703-E7B5DBBF-6FEE-4026-97B8-FB595BE992DB

P932

Q28078703-C6A356F8-D342-4309-BC2F-9D6835296B84

P3181

P356

P1433

P1476

Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials

@en

P2093

Benjamin Lu

http://www.w3.org/2001/XMLSchema#string

Brooke Green

http://www.w3.org/2001/XMLSchema#string

Flávia Lopes

http://www.w3.org/2001/XMLSchema#string

Jacqueline Farr

http://www.w3.org/2001/XMLSchema#string

Terence Van Raay

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic screen for micro-RNAs regulating the canonical Wnt pathway

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

An intrinsically labile α-helix abutting the BCL9-binding site of β-catenin is required for its inhibition by carnosic acid

Comprehensive molecular characterization of human colon and rectal cancer

Wnt/beta-catenin signaling: components, mechanisms, and diseases

Wnt signaling, lgr5, and stem cells in the intestine and skin

Targeting RTK Signaling Pathways in Cancer

Development of anticancer agents targeting the Wnt/β-catenin signaling

Wnt/β-catenin signaling and disease

P31

scholarly article

P3181

3749133

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/CANCERS8090082

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27598201

http://www.w3.org/2001/XMLSchema#string

P921

P932

5040984

http://www.w3.org/2001/XMLSchema#string